PRAGUE, June 9 - The Czech health ministry recommended on Wednesday that only people over 60 years old should receive COVID 19 vaccines from AstraZeneca and Johnson Johnson due to a potential risk of bleeding head wounds.
Scientists and the U.S. and European drug regulators have been seeking an explanation for what has induced rare but potentially deadly clots accompanied by low blood platelet counts which are leading some countries to halt or limit the use of AstraZeneca and J&J vaccines.
The Czech Health Ministry said it made the decision after responding to recommendations from the country's drug regulator SUKL and the Czech Vaccination Society.
U.S. politicians and others have pointed out that the benefits of having AstraZeneca or J&J shots outweigh potential risks.
In the countries of 10.7 million, the vaccinations have accelerated in the past week with the two-dose jab of Pfizer making up the majority of supply in the central European nation.